Dr. Renumathy Dhanasekaran, MD, PhD

Dr. Dhanasekaran practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Dhanasekaran's NPI, 1609008143, was assigned on August 18, 2009. Dr. Dhanasekaran graduated from Bangalore Medical College in 2004. Dr. Dhanasekaran holds California license A136461.

Dr. Dhanasekaran's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Dhanasekaran's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Dhanasekaran is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Dhanasekaran to 1 more hospital, named with a free account. Dr. Dhanasekaran's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhanasekaran practices, 3 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Dhanasekaran's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Dhanasekaran is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Dhanasekaran's licenses on file in 3 states: California, Florida and Minnesota.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal infection, hepatitis c and upper GI endoscopy among the conditions Dr. Dhanasekaran treats.

CMS data shows 289 Medicare services from Dr. Dhanasekaran across 7 procedure codes in 2024, for 174 Medicare patients. Medicare paid $38,979 for them.

CMS counts 174 Medicare patients who saw Dr. Dhanasekaran in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhanasekaran's median patient age at 55, with 57% women.

In 2024, Dr. Dhanasekaran wrote 223 Medicare Part D claims for 48 patients. 84% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $15,533 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dhanasekaran for performance year 2024, reported as part of a group. Dr. Dhanasekaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dhanasekaran as offering telehealth. CMS counts 28 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Dhanasekaran, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 58 papers to Dr. Dhanasekaran, published from 2009 to 2024. 2020 was the busiest year, with 11. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Liver Cirrhosis. Dr. Dhanasekaran has published most often in J Hepatol. Dr. Dhanasekaran's most frequent co-authors are Dean Felsher, MD, Nia Adeniji, MD and Costica Aloman, MD.

CMS Open Payments shows 4 general payments to Dr. Dhanasekaran from 3 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 88% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,611.

Dr. Dhanasekaran graduated from Bangalore Medical College in 2004. Dr. Dhanasekaran is a member of ACP.

Dr. Dhanasekaran is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.